CompletedPhase 2NCT03485976
Ixekizumab in the Treatment of Pityriasis Rubra Pilaris (PRP)
Studying Pityriasis rubra pilaris
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Oregon Health and Science University
- Principal Investigator
- Teri Greiling, MD, PhDOregon Health and Science University
- Intervention
- Ixekizumab(drug)
- Enrollment
- 12 enrolled
- Eligibility
- 18-99 years · All sexes
- Timeline
- 2018 – 2020
Study locations (1)
- Oregon Health and Science University, Portland, Oregon, United States
Collaborators
Eli Lilly and Company
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03485976 on ClinicalTrials.govOther trials for Pityriasis rubra pilaris
Additional recruiting or active studies for the same condition.